These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27503643)

  • 41. Targeting lipid esterases in mycobacteria grown under different physiological conditions using activity-based profiling with tetrahydrolipstatin (THL).
    Ravindran MS; Rao SP; Cheng X; Shukla A; Cazenave-Gassiot A; Yao SQ; Wenk MR
    Mol Cell Proteomics; 2014 Feb; 13(2):435-48. PubMed ID: 24345785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules.
    Danilchanka O; Pires D; Anes E; Niederweis M
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2328-36. PubMed ID: 25645841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype.
    Toro JC; Hoffner S; Linde C; Andersson M; Andersson J; Grundström S
    Microbes Infect; 2006 Jul; 8(8):1985-93. PubMed ID: 16793311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [First isolation of tuberculous mycobacteria in man and animals in Chad].
    Diguimbaye C; Schelling E; Pfyffer GE; Baggi F; Ngandolo R; Ndoutamia G; Tanner M; Zinsstag J
    Med Trop (Mars); 2004; 64(5):482-5. PubMed ID: 15771018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Propionate prevents loss of the PDIM virulence lipid in Mycobacterium tuberculosis.
    Mulholland CV; Wiggins TJ; Cui J; Vilchèze C; Rajagopalan S; Shultis MW; Reyes-Fernández EZ; Jacobs WR; Berney M
    Nat Microbiol; 2024 Jun; 9(6):1607-1618. PubMed ID: 38740932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrazinamide susceptibility testing in all isolates of the Mycobacterium tuberculosis complex - a critical analysis.
    Cunha J
    Rev Port Pneumol; 2012; 18(4):188-9. PubMed ID: 22257727
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp.
    Arai M; Kamiya K; Pruksakorn P; Sumii Y; Kotoku N; Joubert JP; Moodley P; Han C; Shin D; Kobayashi M
    Bioorg Med Chem; 2015 Jul; 23(13):3534-41. PubMed ID: 25934225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
    Aragón LM; Garrigó M; Moreno C; Español M; Coll P
    J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis.
    Gopal P; Yee M; Sarathy J; Low JL; Sarathy JP; Kaya F; Dartois V; Gengenbacher M; Dick T
    ACS Infect Dis; 2016 Sep; 2(9):616-626. PubMed ID: 27759369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs.
    Pisu D; Provvedi R; Espinosa DM; Payan JB; Boldrin F; Palù G; Hernandez-Pando R; Manganelli R
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimycobacterial activity of linezolid against multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis in Iran.
    Kazemian H; Haeili M; Kardan Yamchi J; Rezaei F; Gizaw Feyisa S; Zahednamazi F; Mohajeri P; Zaker Bostanabd S; Hashemi Shahraki A; Imani Fooladi AA; Feizabadi MM
    Int J Antimicrob Agents; 2015 Jun; 45(6):668-70. PubMed ID: 25795315
    [No Abstract]   [Full Text] [Related]  

  • 53. Depletion of resuscitation-promoting factors has limited impact on the drug susceptibility of Mycobacterium tuberculosis.
    Kana BD; Mizrahi V; Gordhan BG
    J Antimicrob Chemother; 2010 Aug; 65(8):1583-5. PubMed ID: 20542905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Total Synthesis of Tetrahydrolipstatin, Its Derivatives, and Evaluation of Their Ability to Potentiate Multiple Antibiotic Classes against
    Khan SS; Sudasinghe TD; Landgraf AD; Ronning DR; Sucheck SJ
    ACS Infect Dis; 2021 Oct; 7(10):2876-2888. PubMed ID: 34478259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotyping and rifampicin and isoniazid resistance in Mycobacterium bovis strains isolated from the lymph nodes of slaughtered cattle.
    Franco MMJ; Ribeiro MG; Pavan FR; Miyata M; Heinemann MB; de Souza Filho AF; Cardoso RF; de Almeida AL; Sakate RI; Paes AC
    Tuberculosis (Edinb); 2017 May; 104():30-37. PubMed ID: 28454647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana.
    Otchere ID; Asante-Poku A; Osei-Wusu S; Aboagye SY; Yeboah-Manu D
    Int J Mycobacteriol; 2017; 6(1):70-75. PubMed ID: 28317808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents.
    Singh U; Akhtar S; Mishra A; Sarkar D
    J Microbiol Methods; 2011 Feb; 84(2):202-7. PubMed ID: 21129420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection.
    Guerrero A; Cobo J; Fortún J; Navas E; Quereda C; Asensio A; Cañón J; Blazquez J; Gómez-Mampaso E
    Lancet; 1997 Dec; 350(9093):1738-42. PubMed ID: 9413465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.
    Broadley SJ; Jenkins PA; Furr JR; Russell AD
    J Med Microbiol; 1995 Dec; 43(6):458-60. PubMed ID: 7473681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.
    Fujiwara M; Kawasaki M; Hariguchi N; Liu Y; Matsumoto M
    Tuberculosis (Edinb); 2018 Jan; 108():186-194. PubMed ID: 29523322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.